In vitro tumor angiogenesis model
View Patent ↗Provided is a method of inducing tubulogenesis in normal endothelial cells comprising co-culturing the normal endothelial cells with tumor cells and forming tubules from the normal endothelial cells.
1. A method of identifying bioactive agents comprising:
a) mixing and co-culturing normal endothelial cells with tumor cells, thereby forming tubules from the normal endothelial cells;
b) contacting the normal endothelial cells with a prospective bioactive agent; and
c) monitoring for changes in tubule formation resulting from the presence of the bioactive agent,
wherein the normal endothelial cells are human endothelial cells that have not been immortalized and wherein the ratio of human endothelial cells to tumor cells is at least 5:1 wherein the tumor cells are glioblastoma cells.
2. The method of claim 1 , wherein the normal endothelial cells are selected from the group consisting of human dermal microvascular endothelial cells, human pulmonary microvascular endothelial cells and human umbilical vein endothelial cells.
3. The method of claim 1 , wherein the contacting step is performed during the co-culturing step.
4. The method of claim 1 , wherein the contacting step is performed prior to the co-culturing step.
5. The method of claim 1 , wherein the step of co-culturing comprises: incubating the normal endothelial cells and tumor cells in an endothelial cell culture medium for at least 1 day; and, forming tubules from the incubated endothelial cells.
6. The method of claim 1 , wherein the glioblastoma cells comprise glioblastoma U251.